T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLDE
2726
Slide Insurance Holdings
SLDE
$2.52B
| $226K | ﹤0.01% |
+14,315
| New | +$235K |
|
2727
RPC Inc
RES
$1.39B
| $225K | ﹤0.01% |
47,087
+2,941
| +7% | +$13.9K |
|
|
STRS
2728
DELISTED
STRATUS PPTYS INC
STRS
| $225K | ﹤0.01% |
10,631
+586
| +6% | +$11K |
|
2729
Paysafe
PSFE
$405M
| $224K | ﹤0.01% |
17,269
+2,492
| +17% | +$33.3K |
|
2730
Unisys
UIS
$210M
| $224K | ﹤0.01% |
57,187
+1,200
| +2% | +$4.87K |
|
2731
Fossil Group
FOSL
$330M
| $223K | ﹤0.01% |
86,628
| – | – |
|
2732
Lantronix
LTRX
$272M
| $223K | ﹤0.01% |
48,722
| – | – |
|
2733
Orion
OEC
$360M
| $223K | ﹤0.01% |
29,333
+2,970
| +11% | +$30K |
|
2734
Teekay
TK
$1.06B
| $223K | ﹤0.01% |
27,199
+1,942
| +8% | +$15.4K |
|
2735
Atomera
ATOM
$212M
| $222K | ﹤0.01% |
50,139
| – | – |
|
2736
SkinHealth Systems
SKIN
$85.9M
| $221K | ﹤0.01% |
110,711
-59,338
| -35% | -$120K |
|
|
SRDX
2737
DELISTED
Surmodics
SRDX
| $221K | ﹤0.01% |
+7,372
| New | +$246K |
|
2738
Choiceone Financial
COFS
$515M
| $219K | ﹤0.01% |
7,537
+375
| +5% | +$11.2K |
|
|
VOYG
2739
Voyager Technologies
VOYG
$2.68B
| $219K | ﹤0.01% |
+7,349
| New | +$254K |
|
2740
ZipRecruiter
ZIP
$388M
| $218K | ﹤0.01% |
51,339
+2,451
| +5% | +$11.5K |
|
2741
Columbia Financial
CLBK
$1.22B
| $217K | ﹤0.01% |
14,402
+1,929
| +15% | +$28.7K |
|
2742
Repay Holdings
RPAY
$317M
| $217K | ﹤0.01% |
41,456
| – | – |
|
2743
Solid Biosciences
SLDB
$974M
| $217K | ﹤0.01% |
35,087
+2,010
| +6% | +$11.8K |
|
2744
Stem
STEM
$55.9M
| $217K | ﹤0.01% |
12,339
-1
| -0% | -$14 |
|
2745
Cytek Biosciences
CTKB
$636M
| $216K | ﹤0.01% |
62,135
+5,314
| +9% | +$19.9K |
|
2746
Absci
ABSI
$1.62B
| $215K | ﹤0.01% |
70,566
+15,863
| +29% | +$43.9K |
|
2747
Agilon Health
AGL
$1.49B
| $215K | ﹤0.01% |
8,342
-5,371
| -39% | -$203K |
|
2748
First Business Financial Services
FBIZ
$601M
| $215K | ﹤0.01% |
4,182
+247
| +6% | +$12.6K |
|
|
VTYX
2749
DELISTED
Ventyx Biosciences
VTYX
| $215K | ﹤0.01% |
69,077
| – | – |
|
2750
Byrna Technologies
BYRN
$97.6M
| $214K | ﹤0.01% |
9,644
+587
| +6% | +$13K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.